Consensus molecular subtype (CMS) as a novel integral biomarker in colorectal cancer: A phase II trial of bintrafusp alfa in CMS4 metastatic CRC.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Amir Mehrvarz Sarshekeh, Michael Lam, Isabel R. Zorrilla, Emma Brey Holliday, Prajnan Das, Bryan K. Kee, Michael J. Overman, Christine Megerdichian Parseghian, John Paul Y.C. Shen, Alda Tam, Edwin Roger Parra Cuentas, Liren Zhang, Xuemei Wang, Dzifa Yawa Duose, Rajyalakshmi Luthra, Neelima Reddy, Dipen M. Maru, Scott Kopetz, Van K. Morris
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: EMD Serono
OpenAlex ID: W3029347933